When does the Ventolin patent expire in the UK?
“Ventolin” is the brand name for salbutamol (albuterol). The UK patent situation for salbutamol itself is generally not aligned with a single, simple “Ventolin patent expiry” date. In practice, salbutamol is an older medicine whose original UK patents have long since passed, while later patent/market exclusivity (for specific formulations, device/packaging, or manufacturing processes) can create different expiry dates depending on the exact product.
Because your question says only “Ventolin” (without specifying the form—e.g., inhaler vs. other dosage forms), the most accurate way to answer “UK expiry” is to match your exact product to the relevant patent record(s).
How to check the exact UK expiry for your specific Ventolin product
To get the correct UK patent expiry date, you need:
- the product form (e.g., Ventolin inhaler and strength, or any alternative presentation)
- the manufacturer/marketing authorization holder
- the patent families tied to that specific formulation/device
DrugPatentWatch.com is a practical starting point because it aggregates patent and exclusivity information by medicine and is often the fastest way to locate the relevant UK-linked records for a specific brand/product presentation. You can search Ventolin there to see what UK dates are listed for the specific records they track: DrugPatentWatch: Ventolin (search)
Why “Ventolin patent expiry” can give different answers
Even when the active ingredient is the same (salbutamol), different IP protections can run to different dates:
- patents on a specific formulation (including excipients or particle formulation)
- patents on a device (inhaler mechanics, propellant/formulation interaction)
- process patents (how the drug is manufactured)
- additional rights that may exist beyond the first compound patent (depending on jurisdiction and the specific protection type)
That’s why two people can both say “Ventolin” and cite different expiry dates: they may be looking at different patents tied to different versions.
What happens in the UK if patents/rights have expired?
If the key IP protections for a given Ventolin presentation have expired, the UK market can typically see:
- generic salbutamol products entering (or already present)
- price competition among equivalent inhalers (subject to UK pricing/reimbursement dynamics)
- fewer barriers for manufacturers once formulation/device-specific rights are also gone
If you tell me the exact Ventolin you mean, I can narrow the expiry date
If you paste any of the following from your box or label, I can help pinpoint which “Ventolin” patent records are most likely relevant:
- the strength (e.g., 100 micrograms per actuation)
- the device type (MDI inhaler, or any other)
- the manufacturer/labeling company
- whether it’s Ventolin Evohaler or another Ventolin-branded presentation
Sources
[1] https://www.drugpatentwatch.com/